Andreas Liebl
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Education
Papers in
-
- Diabetes Treatment and Management 7
- Diabetes Management and Research 5
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 1
- Diabetes Management and Education 1
-
- Metabolism, Diabetes, and Cancer 3
- Co-authors
- É. Eschwège (1 shared paper)Kamlesh Khunti (5 shared papers)Domingo Orozco‐Beltrán (3 shared papers)Jean‐François Yale (2 shared papers)Salvatore Caputo (2 shared papers)A Neiss (1 shared paper)U Reitberger (1 shared paper)Todd H. Wagner (1 shared paper)
- Journals
- Primary care diabetes (2 papers)Diabetes Obesity and Metabolism (1 paper)Diabetic Medicine (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)Diabetes Therapy (1 paper)
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Andreas Liebl
17 papers receiving 495 citations
Peers
Comparison fields: 5 of 55
- Endocrinology, Diabetes and Metabolism 283
- Family Practice 11
- Pharmacology 25
- Physiology 37
- Surgery 57
Countries citing papers authored by Andreas Liebl
This map shows the geographic impact of Andreas Liebl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Liebl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Liebl more than expected).
Fields of papers citing papers by Andreas Liebl
This network shows the impact of papers produced by Andreas Liebl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Liebl. The network helps show where Andreas Liebl may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Liebl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 186 | |
| 2 | 2011 | 66 | |
| 3 | 2001 | 50 | |
| 4 | 2015 | 48 | |
| 5 | 2009 | 44 | |
| 6 | 2018 | 32 | |
| 7 | 2020 | 17 | |
| 8 | 2012 | 12 | |
| 9 | 2010 | 12 | |
| 10 | 2022 | 10 | |
| 11 | 2018 | 10 | |
| 12 | 2006 | 8 | |
| 13 | 2016 | 7 | |
| 14 | 2013 | 7 | |
| 15 | 2010 | 2 | |
| 16 | 2019 | 1 | |
| 17 | 2020 | 1 |
About Andreas Liebl
Andreas Liebl is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Epidemiology, Clinical Biochemistry and Pharmacy, having authored 17 papers that have together received 513 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (7 papers), Diabetes Management and Research (5 papers), Metabolism, Diabetes, and Cancer (3 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (1 paper), Metabolism and Genetic Disorders (1 paper), Renal Transplantation Outcomes and Treatments (1 paper), Diabetes Management and Education (1 paper) and Obesity and Health Practices (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (283 citations), Family Practice (11 citations), Pharmacology (25 citations), Physiology (37 citations) and Surgery (57 citations). Andreas Liebl has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include É. Eschwège, Kamlesh Khunti, Domingo Orozco‐Beltrán, Jean‐François Yale, Salvatore Caputo, A Neiss, U Reitberger, Todd H. Wagner, Claudia Nicolay and Conxa Castell. Their work appears in journals such as Primary care diabetes, Diabetes Obesity and Metabolism, Diabetic Medicine, The Journal of Clinical Endocrinology & Metabolism and Diabetes Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.